BYND Cannasoft Enterprises Inc. Indicators settlement for the acquisition of Israel-based Ziggy Carmel Initiatives & Investments Ltd. A share swap settlement is valued at US$28 million.

[ad_1]

BYND Cannasoft Enterprises, Inc.

BYND Cannasoft Enterprises, Inc.

ZC has patent pending mental for a CBD-based therapeutic system mixed with software program designed to deal with phenomena associated to ladies’s well being points by regulating the circulate of low-concentration CBD oils into the delicate tissues of the feminine reproductive system. is the proprietor of the property.

VANCOUVER, British Columbia, September 18, 2022 (Globe Newswire) — BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND, (“bnd” both “firm”) at this time introduced that it has signed a share buy settlement to amass 100% possession of Ziggy Carmel Initiatives & Investments Ltd. ,ZC“) which holds a patent pending mental property for a medical system (“”Simple-G Gadgets“) that makes use of low concentrations of CBD oils, resembling hemp seed oil and different pure oils, to deal with some ladies’s well being points. Below the phrases of the share buy settlement, the corporate will situation 7,920,000 frequent shares to the proprietor of ZC at a worth of $4.735 per share (topic to closing the transaction by October 10, 2022) and US$100,000 to cowl its authorized bills. pays The closing of the transaction is topic to sure customary circumstances. BYND expects the transaction to shut this month.

The EZ-G system is a singular, patent-pending system that, mixed with proprietary software program (Provisional Software), controls the circulate of low-concentration CBD oils into the delicate tissues of the feminine reproductive system. in accordance with analysis1 Held around the globe, remedy with low-concentration CBD oils can relieve candida, dryness, scars and plenty of different feminine well being issues.

BYND intends to pursue the ultimate registration of the patent and set up a advertising and gross sales system for the EZ-G system. The corporate’s ‘Go to Market’ strategic plan is predicated on mixed B2B and B2C gross sales. A number of research have proven that CBD interacts with the endocannabinoid system, which is a grasp regulatory system with receptors across the physique. By activating these receptors, CBD might have well being advantages that assist make intercourse extra accessible and pleasing by decreasing stress, boosting one’s temper, selling physique leisure, and treating vaginal points. In keeping with the Brightfield Group, a hashish {industry} knowledge analysis agency, gross sales of CBD merchandise may attain $11 billion2 until 2027. Latest Zion Market Analysis Research3 signifies that the worldwide gynecological units market measurement was estimated to be $10.8 billion in 2021 and is projected to exceed $19.5 billion by 2028 with a compound annual development charge (CAGR) of roughly 10.3 %.

There have been no regulatory filings associated to the system in the USA and the corporate has no intention of selling the system in any jurisdiction except it’s authorised by an relevant regulator in the USA, together with the Meals and Drug Administration Is.

BYND CEO and Director Yaftah Ben Yaakov mentioned, “As we full the acquisition of ZC, we plan to get off the bottom initially by securing any vital regulatory approvals from the suitable authorities. We are going to proceed to register. The patent, which incorporates greater than 100 claims, manufacturing of prototypes and graduation of validation testing, and contracts with suppliers for the manufacturing of the tools and oils used within the EZ-G system.

“The demand for a singular system, mixed with software program such because the EZ-G system, stems from the growing incidence of persistent circumstances and the adoption of self-health administration. Utilizing a tool at house is a really cost-effective remedy, and it Opens an enormous channel for tens of millions of ladies.” Mr. Ben Yaakov continued, “We stay up for utilizing the data gained within the area of medical hashish to considerably enhance the standard of life of ladies affected by the signs described above.”

About BYND Cannasoft Enterprises Inc.

BYND is an built-in software program/hashish firm primarily based in Israel.

crm software program

BYND owns and markets a proprietary buyer relationship administration (CRM) software program product, referred to as a “Profit CRM”. BYND’s Profit CRM software program allows small and medium-sized companies to optimize their day-to-day enterprise actions resembling gross sales administration, personnel administration, advertising, name middle actions and asset administration. BYND’s next-generation Profit CRM platform is now prepared for beta testing.

Hashish CRM

Constructing on its 20 years of expertise in CRM software program, BYND has not too long ago begun improvement of an modern new CRM platform designed particularly to fulfill the wants of the medical hashish {industry}. This new platform would be the first of its variety for the medical hashish sector and the corporate is assured that it’s going to remodel the {industry} right into a extra organized, accessible and worth clear market. Knowledge and data collected by way of the operation of Hashish Farm (see under) and the merchandise it produces will permit BYND to check its new hashish CRM platform and alter the platform as wanted. Moreover, working a hashish farm and promoting medical hashish will present extra income to additional help BYND in the course of the preliminary roll-out years of its hashish CRM platform.

hashish farm

BYND is within the means of acquiring approval for the switch of a major rising license for rising medical hashish in Israel and intends to construct a 3.7-acre farm facility close to Ashkelon Israel to develop medical hashish. The corporate’s plans embody the development of 4 state-of-the-art greenhouses, housing roughly 2.5 acres of complete rising space. BYND estimates that after absolutely operational its hashish farm facility will be capable to produce 7,500 kilograms of uncooked hashish annually. BYND intends to work with strategic companions to develop and market new, proprietary cannabis-infused merchandise on the market and for export all through Israel. For extra info please go to the corporate’s web site: www.cannasoft‐crm.com, CSE’s web site: www.thecse.com/en/listings/life‐sciences/byndcannasoft‐enterprises‐inc and at SEDAR: www.sedar.com.

Gabby Cabazzo
chief Monetary Officer
Tel: (604) 8336820
E mail: ir@cannasoft‐crm.com

For media and investor relations, please contact:

David L Kugelman
(866) 692-6847 Toll Free – US and Canada
(404) 281-8556 MOBILE & WHATSAPP
[email protected]
Skype: kugasusa

BYND Cannasoft Press Launch: September 19, 2022.

Cautionary Word Relating to Ahead-looking Statements

This press launch comprises forward-looking statements that contain dangers and uncertainties that would trigger precise outcomes to vary materially from these made within the statements. When used on this doc, the phrases “may”, “will”, “may”, “will”, “intend”, “plan”, “estimate”, “imagine”, “estimate” , “anticipate” and comparable expressions are supposed to establish forward-looking statements. Ahead-looking statements on this press launch embody, with out limitation, the expectation that BYND’s acquisition of ZC shall be accomplished this month, {that a} patent shall be issued for the EZ-G system that has been utilized for and that each one markets through which it’s supposed that the EZ-G Machine shall be bought, and that each one vital regulatory approvals for the sale of the EZ-G Machine shall be obtained in a well timed method. Such statements replicate our present views with respect to future occasions and are topic to such dangers and uncertainties. A number of components may trigger our precise outcomes to vary materially from these made within the statements, together with these mentioned in our filings with the Securities Regulatory Authorities of Canada and the US Securities and Change Fee. If a number of of those dangers and uncertainties, resembling forex and rate of interest fluctuations, elevated competitors, and normal financial and market components, happen or if the assumptions contained within the forward-looking statements show to be false, precise outcomes might differ materially from these described herein. might differ bodily. as supposed, deliberate, anticipated, or anticipated. We don’t intend or assume any obligation to replace these forward-looking statements, besides as required by legislation. Shareholders are cautioned to not place undue reliance on such forward-looking statements.

Neither the US Securities and Change Fee nor CSE has reviewed, authorised or disapproved the contents of this press launch.

1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924206/

2 https://www.cannabisbusinesstimes.com/article/brightfield-group-estimates-us-cbd-market-growth-dependent-fda-guidance/

3 https://www.prnewswire.com/news-releases/statistics-on-gynecology-devices-market-size–share-worth-over-usd-19501-20-million-by-2028–exhibit-a- cagr-of-10-30-industry-trends-demand-value-analysis–forecast-report-by-zion-market-research-301601656.html

[ad_2]

Supply hyperlink